(Date:11/24/2009)...RNewswire/--HealthRoboticstodayannounced,thatithas...,investors.ThisrecentlyformedToronto-basedcompanyw...dwillmarket,install,andsupport,HealthRobotics,i.v....aryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),an...ssistanceonan"asneeded,basis"toitsstrategicpartner...
(Date:11/24/2009)...e-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqand...JaffrayHealthCareConference.Theconferencewillbehel...TIwillpresentonTuesday,December1at11:00a.m.Eastern...esentationwillbeavailableat www.celltherapeutics.c... ,PiperJaffrayHealthCareConference,NewYorkPalaceH...
(Date:11/23/2009)...ra-fast communication, computation and more powerf...ng to use quantum states as carriers of informatio...cists have shown, mathematically, how to gently te...hile keeping the information intact. Their work is... Letters and highlighted with a Viewpoint in Phy...
(Date:11/23/2009)...Newswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YM...hatidentifiesandadvancesadiverseportfolioofpromisi...nt,todayreportedthatCytopia(ASX:CYT)hascommenceden...orally-administeredJAK1/JAK2inhibitor.Thetrialisbe...posaltomergeCytopiaintoYMhasbeenpreviouslyannounce...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...uticals,Inc. (Nasdaq: ANDS ), a clinical-stage bi...ient care by developing novel medicines in the are... financial results and,highlights for the third qu...make rapid progress in both of our hepatitis C,dev...ident and CEO of,Anadys. "We completed our first c...
...all/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ... Phase I,Study to Evaluate Systemic Wild-Type Reov...n Patients with Advanced Malignancies" will be ava...al of Immunotherapy, the official,journal of the I...cer,(iSBTc). The principal investigator for the tr...
...ne today announced,that researchers will present e... at the Annual Meeting of the American College of ...oscone Center in San Francisco, California., "Med...ns for patients,struggling with systemic autoimmun...ice president, clinical development, respiratory,i...
Other Biology Technology:Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 7Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 8Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 2MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 3... In recent years, a growing scarcity of energy com...ey geopolitical risks and threats, such as conflic...nalism. However, a study released this week by Ric...uggests that, taken individually, many of the risk...rophic than they seem at first glance. The executi...
... Fishery biologist Sandy Sutherland looks through ...h earbones, known as otoliths, each showing annual...o determine the age of the fish, then moves on to ...nd is one of a small team at NOAAs Northeast Fishe...itical to stock assessments needed to manage the n...
... This press release is available in German . , ...cost us in the long term" How much do national eco...nd" And what price will we have to pay if we do no...nomics of Ecosystems and Biodiversity - project is...ukhdev, who is head of Deutsche Bank,s Global Mark...
Other Biology News:Baker Institute study, conference weigh risks for global energy markets 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 3Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 4Biodiversity as a natural resource 2Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX
Goat Anti-Human AGAP1 / Centaurin, gamma 2 Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: